教職人員
|
林淑文
研究領域：臨床藥學、抗生素之臨床藥動學與藥效學
本職：副教授 / 臺大醫院藥劑部主任
| 最高學歷 | : | 8/2000-5/2003 School of Pharmacy and Pharmaceutical Sciences Purdue University, West Lafayette, IN Doctor of Pharmacy 9/1996-6/1998 Graduate Institutes of Pharmaceutical Sciences National Taiwan University, Taipei, Taiwan Master of Science 10/1992-6/1996 School of Pharmacy National Taiwan University, Taipei, Taiwan Bachelor of Science |
| 經歷 | : | 2007.10-present：Clinical Pharmacist, Department of Pharmacy, National Taiwan University Hospital 9/2005-7/2007 Clinical Pharmacist, Infectious Diseases / Clinical Instructor Department of Pharmacy Services Hahnemann University Hospital, Philadelphia, PA University of Sciences in Philadelphia, Philadelphia College of Pharmacy 7/2004-6/2005 Pharmacy Specialty Resident in Infectious Diseases / Clinical Instructor Department of Pharmacy Services and College of Pharmacy University of Michigan Health System, Ann Arbor, MI 7/2003-6/2004 ASHP Accredited Pharmacy Practice Resident / Clinical Instructor Department of Pharmacy Services and College of Pharmacy, University of Michigan Health System, Ann Arbor, MI 9/2001-8/2002 Undergraduate Research Assistant Department of Pharmacy Practice, Purdue University, West Lafayette, IN 6/2001-8/2001 Summer Undergraduate Research Fellow Department of Pharmacy Practice, Purdue University, Indianapolis, IN 2/2000-7/2000 Teaching Assistant School of Pharmacy, National Taiwan University, Taipei, Taiwan 8/1999-1/2000 Clinical Research Associate Abbott Laboratories Service Corp., Taiwan Branch, Taipei, Taiwan 7/1998-7/1999 Research Assistant College of Public Health, National Taiwan University, Taipei, Taiwan |
| 榮譽 | : | May 2003 Doctor of Pharmacy with Distinction Spring 2002 Robert C. Anderson Family scholarship Fall 2001- Rho Chi Society membership Spring 2001 Helen K. Carney’s scholarship Fall 2000-Spring 2002 Dean’s List and Semester Honors Fall 1996 Research Creativity Award from the National Science Council, Taiwan |
| 研究領域 | : | 臨床藥學、抗生素之臨床藥動學與藥效學 |
| 研究方向 | : | 1. 抗生素之療劑監測（TDM）與個別化藥物治療 2. 藥品之臨床療效與不良反應評估 3. 藥事服務之評估 |
Ventricular Arrhythmia and Sudden Death Risk With Concomitant Antipsychotic and SSRI Use
(2026-04-09) Chien, Hsiu-Ting ; SHU-WEN LIN ; Kung, Te-Jung ; Dong, Yaa-Hui ; CHI-CHUAN WANG ; Toh, Sengwee ; TZUNG-JENG HWANG ; FANG-JU LIN
Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in Taiwan.
(2026-03) Wang, Yu-Wen ; Cheng, Chih-Ning ; Lin, Chien-Ting ; Xavier Cheng-Hong Tsai ; Huang, Jiun-Da ; Hsieh, Zong-Da ; Liao, Xiu-Wen ; FANG-JU LIN ; YEE-CHUN CHEN ; CHING-HUA KUO ; SHU-WEN LIN ; SHANG-JU WU
The Impact of QT-Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case-Crossover Study
(2025-02) Chien, Hsiu-Ting ; FANG-JU LIN ; JYH-MING JIMMY JUANG ; SHU-WEN LIN
Recurrence of Diabetic Foot Complications: A Domino Effect Leading to Lethal Consequences-Insights From a National Longitudinal Study.
(2024-06) Hsu, Chun-Chien ; Lai, Hsi-Yu ; Lin, Hung-Yu ; SUNG-CHING PAN ; Chen, Liang-Kung ; NAI-CHEN CHENG ; FEI-YUAN HSIAO ; SHU-WEN LIN
The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases
(2024-02-01) Pang, A. H. ; SHU-WEN LIN ; Yang, J. H. ; Wang, P. H. ; Pan, S. W. ; Wei, Y. F. ; CHUNG-YU CHEN ; Lee, H. S. ; Wu, T. S. ; Chang, C. H. ; CHIN-CHUNG SHU
(2026-04-09) Chien, Hsiu-Ting ; SHU-WEN LIN ; Kung, Te-Jung ; Dong, Yaa-Hui ; CHI-CHUAN WANG ; Toh, Sengwee ; TZUNG-JENG HWANG ; FANG-JU LIN
Voriconazole as a Secondary Prophylaxis for Invasive Fungal Infections in Allogeneic Hematopoietic Stem Cell Transplantation: Real-world Evidence From a Major Transplantation Center in Taiwan.
(2026-03) Wang, Yu-Wen ; Cheng, Chih-Ning ; Lin, Chien-Ting ; Xavier Cheng-Hong Tsai ; Huang, Jiun-Da ; Hsieh, Zong-Da ; Liao, Xiu-Wen ; FANG-JU LIN ; YEE-CHUN CHEN ; CHING-HUA KUO ; SHU-WEN LIN ; SHANG-JU WU
The Impact of QT-Prolonging Medications and Drug–Drug Interactions on QTc Interval Prolongation in Hospitalized Patients: A Case-Crossover Study
(2025-02) Chien, Hsiu-Ting ; FANG-JU LIN ; JYH-MING JIMMY JUANG ; SHU-WEN LIN
Recurrence of Diabetic Foot Complications: A Domino Effect Leading to Lethal Consequences-Insights From a National Longitudinal Study.
(2024-06) Hsu, Chun-Chien ; Lai, Hsi-Yu ; Lin, Hung-Yu ; SUNG-CHING PAN ; Chen, Liang-Kung ; NAI-CHEN CHENG ; FEI-YUAN HSIAO ; SHU-WEN LIN
The timing of intravenous antibiotics and clinical outcomes of Mycobacterium abscessus complex lung diseases
(2024-02-01) Pang, A. H. ; SHU-WEN LIN ; Yang, J. H. ; Wang, P. H. ; Pan, S. W. ; Wei, Y. F. ; CHUNG-YU CHEN ; Lee, H. S. ; Wu, T. S. ; Chang, C. H. ; CHIN-CHUNG SHU
Clinical Efficacy and Pharmacokinetics of Cefiderocol for Carbapenem-Resistant Enterobacterales Infections: with Special Emphasis on Treatment Strategy of Ndm-Producing Enterobacterales = Cefiderocol用於治療碳青黴烯抗藥性腸桿菌感染之臨床療效與藥物動力學分析: 特別著重產NDM碳青黴烯酶腸桿菌之治療策略
(2025-08-01～) YU-SHAN HUANG
HIV/AIDS Control and Study Center (VI) = 愛滋病防治整合型中程計畫─愛滋病防治中心 (VI)
(2026-01-01～) CHIEN-CHING HUNG
Optimization of Anti-Mycobacterial Therapy among Patients with Anti-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (Extended Study) (II) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (延伸研究) (II)
(2024-08-01～) UN-IN WU
Establish a Novel Model of Pharmaceutical Care via Precision Medicine for Estrogen Receptor (Er) Positive Early Stage Breast Cancer Patients with Oral Tamoxifen Treatment
(2023-08-01～) LI-JIUAN SHEN
Optimization of Anti-Mycobacterial Therapy among Patients with Ani-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (I) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (I)
(2023-08-01～) UN-IN WU
(2025-08-01～) YU-SHAN HUANG
HIV/AIDS Control and Study Center (VI) = 愛滋病防治整合型中程計畫─愛滋病防治中心 (VI)
(2026-01-01～) CHIEN-CHING HUNG
Optimization of Anti-Mycobacterial Therapy among Patients with Anti-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (Extended Study) (II) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (延伸研究) (II)
(2024-08-01～) UN-IN WU
Establish a Novel Model of Pharmaceutical Care via Precision Medicine for Estrogen Receptor (Er) Positive Early Stage Breast Cancer Patients with Oral Tamoxifen Treatment
(2023-08-01～) LI-JIUAN SHEN
Optimization of Anti-Mycobacterial Therapy among Patients with Ani-Interferon-Gamma Autoantibodies through Therapeutic Drug Monitoring (I) = 抗丙型干擾素自體抗體病人使用抗分枝桿菌藥物之療效監測與精準劑量探討 (I)
(2023-08-01～) UN-IN WU